Published on January 28, 2025, 03:05 PM UTC
Hims & Hers (HIMS) stock plunged 26% on Tuesday despite a better-than-expected Q4 report, as investors worry about potential revenue loss from discontinued compounded weight-loss drugs. CFO Yemi Okupe downplayed these concerns, highlighting the company's diversified revenue stream and strong outlook for 2024, but Wall Street remains cautious amid industry-wide changes in semaglutide availability.
Published on: February 25, 2025, 05:01 PM UTC
South Carolina is a top destination for out-of-state moves, with a booming population and job market, attracting residents seeking a warmer climate, lower cost of living, and coastal communities.
Published on: February 22, 2025, 06:01 PM UTC
Major homebuilders face challenges in the spring season due to a potential trade war and high mortgage rates. DR Horton reports a decline in orders, Toll Brothers lowers guidance. Rising land prices, competition, and tariff concerns add to industry uncertainties.
Published on: February 22, 2025, 01:00 PM UTC
Japan's Seven & i Holdings picks Bain Capital to buy stake in non-core unit York Holdings, reportedly for over $4.7 billion.
Published on: February 22, 2025, 11:00 AM UTC
Trump's 25% steel tariffs threaten to further inflate construction costs and raise rents for apartments and condos, especially high-rise buildings. Developers may delay projects or seek exemptions as the US faces a housing shortage.
Published on: February 22, 2025, 10:00 AM UTC